Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
What It Targets Our Epithalon + GHK-Cu combination peptides are designed to target: Cellular aging pathways, including telomere attrition, oxidative stress, and circadian disruption in midlife and beyond. Sleep quality and recovery in clients with agerelated melatonin decline, tired but wired evenings, or irregular sleepwake cycles. Visible skin agingfine lines, laxity, dullness, and textural changesthrough enhanced collagen, elastin, and dermal remodeling. Overall biological age markers in clients already investing in nutrition, exercise, stress work, and other Better Med Spa protocols (GLP1s, Tesamorelin, etc.)
These numbing agents may provide temporary relief but often lead to contact dermatitis, adding another layer of irritation to an already painful situation
Future work should focus on 3D cultures and in vivo animal models that more accurately mimic a natural cellular environment, allowing a true evaluation of the peptides effectiveness as an anti-aging compound
HCC / Risk Adjustment (v28) Diabetes mellitus is among the most significant conditions in Medicare Advantage (MA) risk adjustment under CMS-HCC Model V28, which became fully operative for payment year 2026 (eliminating the 20242025 V24/V28 blend)
If youve already been diagnosed or experience common deficiency symptoms, we may proceed without testing
US$ 28.27
US$ 29.69
US$ 20.74
